1
|
AZT-3TC-LPV/r
|
3.65
|
U
|
U
|
U
|
40
|
+ 323
|
2
|
d4T-3TC-IDV/r
|
2.36
|
U
|
U
|
U
|
490
|
+ 231
|
3
|
d4T-ABC-LPV/r
|
5.36
|
D
|
D
|
D
|
338
|
+180
|
4
|
3TC-TDF-SQV-ATV/r
|
5.73
|
U
|
U
|
NA
|
92
|
+161
|
5
|
d4T-3TC-NFV
|
3.36
|
U
|
U
|
U
|
261
|
+147
|
6
|
TDF-FTC-ATV/r
|
5.40
|
D
|
NA
|
NA
|
10
|
+140
|
7
|
AZT-3TC-LPV/r
|
4.05
|
U
|
U
|
U
|
62
|
+136
|
8
|
d4T-3TC-IDV
|
NA
|
NA
|
NA
|
NA
|
527
|
+ 89
|
9
|
d4T-3TC-LPV/r
|
4.36
|
U
|
U
|
U
|
128
|
+ 67
|
10
|
ddI-TDF-IDV/r
|
3.60
|
D
|
U
|
NA
|
120
|
+ 50
|
11
|
d4T-3TC-NFV
|
4.36
|
D
|
D
|
D
|
380
|
+ 49
|
12
|
AZT-3TC-FPV/r
|
3.49
|
D
|
D
|
NA
|
290
|
+ 40
|
13
|
AZT-3TC-IDV
|
5.29
|
U
|
U
|
D
|
280
|
+ 21
|
14
|
d4T-3TC-NFV
|
4.36
|
D
|
D
|
NA
|
257
|
- 14
|
15
|
3TC-TDF-IDV/r
|
2.40
|
D
|
D
|
NA
|
180
|
- 31
|
|
Mean
|
4.13
| | | |
230
|
+106
|
|
Median
|
4.21
| | | |
257
|
+89
|
PI-sparing regimens
|
16
|
AZT-3TC-ABC
|
3.01
|
D
|
D
|
D
|
150
|
+ 57
|
17
|
d4T-3TC-ABC-TDF
|
3.36
|
U
|
U
|
U
|
630
|
+12
|
18
|
ddI-TDF-ABC
|
4.05
|
D
|
D
|
D
|
174
|
- 8
|
19
|
AZT-3TC-ABC
|
5.07
|
D
|
D
|
NA
|
166
|
- 53
|
20
|
AZT-3TC-ABC
|
2.40
|
D
|
NA
|
NA
|
737
|
- 60
|
21
|
3TC-ABC-TDF
|
3.36
|
NA
|
D
|
NA
|
195
|
- 61
|
22
|
AZT-3TC-ABC
|
4,78
|
D
|
D
|
D
|
280
|
- 62
|
|
Mean
|
3.72
| | | |
333
|
-25
|
|
Median
|
3.36
| | | |
195
|
.53
|
Regimens not included in the comparison above
|
23
|
AZT-3TC-NVP
|
NNRTI is not active, suboptimal bitherapy
| | | | | |
24
|
AZT
|
Suboptimal monotherapy
| | | | | |
25
|
ddI-d4T-EFV
|
NNRTI is not active, suboptimal bitherapy
| | | | | |
26
|
AZT-3TC-NFV
|
Therapy switched after 1 month
| | | | | |
27
|
3TC-ABC-FPV/r
|
Therapy switched after 1 month
| | | | | |
28
|
AZT-3TC-SQV/r
|
Therapy started end of 2006
| | | | | |
29
|
AZT-3TC-LPV/r
|
Therapy started end of 2006
| | | | | |
30
|
AZT
|
Pregnancy, prevention MTCT
| | | | | |
31
|
AZT
|
Pregnancy, prevention MTCT
| | | | | |
32
|
AZT-3TC-LPV/r
|
Pregnancy, prevention MTCT
| | | | | |
33
|
3TC-d4T
|
Lost to follow-up
| | | | | |
34
|
ddI-d4T-ABC-SQV-NFV
|
Lost to follow-up
| | | | | |